OR WAIT null SECS
March 02, 2005
In this time of liability reform, pharma deserves the chance to align its economic interests with its ethical obligations to the patient.
As newer and more elaborate hardware and software systems are installed in automated manufacturing environments, companies are further incorporating good practices into their validation process.
The authors evaluate the implications of product photosensitivity and how it influences various aspects of product development. They discuss a product photosensitivity classification system and present a photosensitive pharmaceutical product case study.
February 24, 2005
CBER Draft Guidance for Spore-Formers and Plasmid Vaccines
February 17, 2005
FDA Creates New Drug Safety Board
Lilly Implements Bar Coding on Individual Insulin Vials
Drug Safety Top Issue for New FDA Commissioner Crawford
February 03, 2005
Generic Drug for HIV/AIDS Gains FDA's Tentative Approval
February 02, 2005
The United States Pharmacopeia should not change its philosophical position on singlet testing.
January 27, 2005
FDA cites Essential Pharmacy Compounding (Omaha) for bulk-compounding of verterinary drugs.